These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15006797)

  • 1. Virucidal efficacy of glutaraldehyde against enteroviruses is related to the location of lysine residues in exposed structures of the VP1 capsid protein.
    Chambon M; Archimbaud C; Bailly JL; Gourgand JM; Charbonné F; Peigue-Lafeuille H
    Appl Environ Microbiol; 2004 Mar; 70(3):1717-22. PubMed ID: 15006797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of glutaraldehyde at low concentrations against capsid proteins of poliovirus type 1 and echovirus type 25.
    Chambon M; Bailly JL; Peigue-Lafeuille H
    Appl Environ Microbiol; 1992 Nov; 58(11):3517-21. PubMed ID: 1336351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative sensitivity of the echovirus type 25 JV-4 prototype strain and two recent isolates to glutaraldehyde at low concentrations.
    Chambon M; Bailly JL; Peigue-Lafeuille H
    Appl Environ Microbiol; 1994 Feb; 60(2):387-92. PubMed ID: 8135510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
    Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
    PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.
    Chambon M; Jallat-Archimbaud C; Bailly JL; Gourgand JM; Charbonne F; Henquell C; Fuchs F; Peigue-Lafeuille H
    Appl Environ Microbiol; 1997 Aug; 63(8):3199-204. PubMed ID: 9251206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
    Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
    J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genome of echovirus 11.
    Dahllund L; Nissinen L; Pulli T; Hyttinen VP; Stanway G; Hyypiä T
    Virus Res; 1995 Feb; 35(2):215-22. PubMed ID: 7762294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.
    Shih SR; Tsai MC; Tseng SN; Won KF; Shia KS; Li WT; Chern JH; Chen GW; Lee CC; Lee YC; Peng KC; Chao YS
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3523-9. PubMed ID: 15328120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.
    Lentz KN; Smith AD; Geisler SC; Cox S; Buontempo P; Skelton A; DeMartino J; Rozhon E; Schwartz J; Girijavallabhan V; O'Connell J; Arnold E
    Structure; 1997 Jul; 5(7):961-78. PubMed ID: 9261087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products.
    Casas I; Palacios GF; Trallero G; Cisterna D; Freire MC; Tenorio A
    J Med Virol; 2001 Sep; 65(1):138-48. PubMed ID: 11505456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes.
    Mulders MN; Salminen M; Kalkkinen N; Hovi T
    J Gen Virol; 2000 Mar; 81(Pt 3):803-12. PubMed ID: 10675418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for serological cross-reactivity between enteroviruses.
    Samuelson A; Forsgren M; Johansson B; Wahren B; Sällberg M
    Clin Diagn Lab Immunol; 1994 May; 1(3):336-41. PubMed ID: 7496972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing.
    Norder H; Bjerregaard L; Magnius LO
    J Med Virol; 2001 Jan; 63(1):35-44. PubMed ID: 11130885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75.
    Oberste MS; Michele SM; Maher K; Schnurr D; Cisterna D; Junttila N; Uddin M; Chomel JJ; Lau CS; Ridha W; Al-Busaidy S; Norder H; Magnius LO; Pallansch MA
    J Gen Virol; 2004 Nov; 85(Pt 11):3205-3212. PubMed ID: 15483233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B.
    Oberste MS; Maher K; Nix WA; Michele SM; Uddin M; Schnurr D; al-Busaidy S; Akoua-Koffi C; Pallansch MA
    Virus Res; 2007 Sep; 128(1-2):34-42. PubMed ID: 17485128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
    Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
    Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses.
    Oberste MS; Maher K; Pallansch MA
    Virus Res; 1998 Aug; 56(2):217-23. PubMed ID: 9783471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomics of the coxsackie B viruses and related enteroviruses.
    Oberste MS
    Curr Top Microbiol Immunol; 2008; 323():33-47. PubMed ID: 18357764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between variation of coxsackievirus B3 VP1 sequence from cerebrospinal fluid of children and severity of damage to central nervous system].
    Chen ZB; Fu ZR; Wu FL; Sui AH; Yang K; Liu XM; Qian N; Zhao N; Chen ZZ
    Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):268-72. PubMed ID: 20654015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.